Evidence map›Paper›PMID 23248776›Full record

ArticleFrontiers in cellular and infection microbiology2012

Toward a molecular pathogenic pathway for Yersinia pestis YopM.

Annette M Uittenbogaard, R Lakshman Chelvarajan, Tanya Myers-Morales, Amanda A Gorman, W June Brickey, Zhan Ye, Alan M Kaplan, Donald A Cohen, Jenny P-Y Ting, Susan C Straley

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. New insights into the putative role of leucine-rich repeat proteins ofFrontiers in cellular and infection microbiology · 2024
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The pathogenic Yersiniae--advances in the understanding of physiology and virulence.Frontiers in cellular and infection microbiology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Annette M UittenbogaardDepartment of Microbiology, Immunology, and Molecular Genetics, University of Kentucky Lexington, KY, USA.
R Lakshman Chelvarajan
Tanya Myers-Morales
Amanda A Gorman
W June Brickey
Zhan Ye
Alan M Kaplan
Donald A Cohen
Jenny P-Y Ting
Susan C Straley
University of Kentucky · USUNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

YopM and protective innate defenses against plagueR01AI067869 · NIAID · UNIVERSITY OF KENTUCKY · PI STRALEY, SUSAN C · 2007 to 2011
$2.2M
Cell Sorter Upgrade for Flow Cytometry Service FacilityS10RR026827 · NCRR · UNIVERSITY OF KENTUCKY · PI COHEN, DONALD A · 2011 to 2011
$600k
NCRR NIH HHS S10 RR026827NCRR NIH HHS S10 RR026827-01A1NIAID NIH HHS 5R01AI67869NIAID NIH HHS R01 AI067869
6 · The paper itself

Abstract

YopM is one of the six "effector Yops" of the human-pathogenic Yersinia, but its mechanism has not been defined. After delivery to J774A.1 monocyte-like cells, YopM can rapidly bind and activate the serine/threonine kinases RSK1 and PRK2. However, in infected mice, effects of Y. pestis YopM have been seen only after 24-48 h post-infection (p.i.). To identify potential direct effects of YopM in-vivo we tested for effects of YopM at 1 h and 16-18 h p.i. in mice infected systemically with 10(6) bacteria. At 16 h p.i., there was a robust host response to both parent and ΔyopM-1 Y. pestis KIM5. Compared to cells from non-infected mice, CD11b(+) cells from spleens of infected mice produced more than 100-fold greater IFNγ. In the corresponding sera there were more than 100-fold greater amounts of IFNγ, G-CSF, and CXCL9, as well as more than 10-fold greater amounts of IL-6, CXCL10, and CXCL1. The only YopM-related differences were slightly lower CXCL10 and IL-6 in sera from mice infected 16 h with parent compared to ΔyopM-1 Y. pestis. Microarray analysis of the CD11b(+) cells did not identify consistent transcriptional differences of ≥4-fold at 18 h p.i. However, at 1 h p.i. mRNA for early growth response transcription factor 1 (Egr1) was decreased when YopM was present. Bone marrow-derived macrophages infected for 1 h also expressed lower Egr1 message when YopM was present. Infected J774A.1 cells showed greater expression of Egr1 at 1 h p.i. when YopM was present, but this pattern reversed at 3 h. At 6 h p.i., Cxcl10 mRNA was lower in parent-strain infected cells. We conclude that decreased Egr1 expression is a very early transcriptional effect of YopM and speculate that a pathway may exist from RSK1 through Egr1. These studies revealed novel early transcriptional effects of YopM but point to a time after 18 h of infection when critical transitional events lead to later major effects on cytokine gene transcription.

Indexed as

AnimalsBacterial Outer Membrane ProteinsBone MarrowCells, CulturedCytokinesDisease Models, AnimalEarly Growth Response Protein 1FemaleGene Expression ProfilingLeukocytes, MononuclearMiceMice, Inbred C57BLMicroarray AnalysisPlagueSpleenTime FactorsBacterial Outer Membrane ProteinsCytokinesEarly Growth Response Protein 1Egr1 protein, mouseVirulence FactorsyopM protein, YersiniachemokinemicroarrayplagueYersiniaYopM

Identifiers

PMID23248776
PMCPMC3518861
OpenAlexW2093815300

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.